NCT06412718View on ClinicalTrials.gov

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Not yet recruitingOBSERVATIONAL

Enrollment

274

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions

Rare DiseasesAniridiaNeurotrophic KeratopathyLimbal Stem Cell DeficiencyOcular Graft-versus-host DiseaseOcular Cicatricial PemphigoidEEC SyndromeCorneal Neovascularization

All Listed Sponsors

lead

IRCCS Ospedale San Raffaele

OTHER

NCT06412718 - Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies | Biotech Hunter | Biotech Hunter